Antitumor activity of the novel nitrosourea S10036 in rodent tumors

S. Filippeschi, T. Colombo, D. Bassani, L. De Francesco, P. Arioli, M. D'Incalci, I. Bartosek, A. Guaitani

Research output: Contribution to journalArticle

Abstract

The activity of the novel anticancer agent diethyl 1-3-(chloroethyl)-3-nitrosoureido ethyl phosphonate (S10036) was investigated on several rodent tumors. S10036 showed a good efficacy, comparable to that of the anticancer agent BCNU, against i.p. transplanted P388 and L1210 leukemias. S10036 was very effective against the primary tumor and metastases of i.m. transplanted M5076 reticular cell sarcoma of the mouse and against subline A of the Walker carcinoma of the rat. It was inactive against rodent tumors resistant to BCNU such as L1210/BCNU, ICIG-Ci4 murine fibrosarcoma and the Walker carcinoma subline B in the rat.

Original languageEnglish
Pages (from-to)1351-1354
Number of pages4
JournalAnticancer Research
Volume8
Issue number6
Publication statusPublished - 1988

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Antitumor activity of the novel nitrosourea S10036 in rodent tumors'. Together they form a unique fingerprint.

  • Cite this

    Filippeschi, S., Colombo, T., Bassani, D., De Francesco, L., Arioli, P., D'Incalci, M., Bartosek, I., & Guaitani, A. (1988). Antitumor activity of the novel nitrosourea S10036 in rodent tumors. Anticancer Research, 8(6), 1351-1354.